The purpose of the company is to oversee the global manufacturing and distribution of certain pharmaceutical products, to drive the commercial strategy and to monitor global business operations, including matters such as market access, manufacturing, research and development, and supply chain activities. The company may hold, develop, improve, manage, protect, exploit, license, enforce, assign, transfer, finance, and dispose of intangible assets such as intellectual property and intellectual property rights, including patents, trademarks, and copyrights. The company may provide administrative, financial, accounting, commercial, and general services to affiliated companies that they need in the context of the development of the group's activities. In particular, the company may provide funds directly or indirectly to its direct or indirect subsidiaries and third parties, including to its direct or indirect shareholders and their direct or indirect subsidiaries, any type of security for its own liabilities and liabilities of other companies (including the direct or indirect shareholders of the company or companies in which these shareholders are direct or indirect shareholders), including pledges or fiduciary transfers or fiduciary assignments of the company's assets or guarantees, enter into securities or otherwise secure or guarantee the company's liabilities or those of these other companies, whether for consideration or not. Furthermore, the company may operate or participate in a liquidity account/concentration of net liquidity (cash pooling) together with the aforementioned companies, including periodic account balancing (balancing), all of this free of charge, on preferential terms, without interest, excluding the pursuit of the company's profits, and taking into account cluster risks. The company may acquire, hold, manage, mortgage, and sell real estate. In the case of transactions involving the purchase of real estate in Switzerland, these are limited to real estate used exclusively for commercial purposes. It is stipulated that real estate held or acquired through investments or properties located in Switzerland or acquired there may only be used for exclusively commercial purposes. The company is authorized to establish and maintain domestic and foreign subsidiaries and branches, represent third parties, conduct business, enter into agreements, and take all other measures or perform other activities that are suitable to promote the purpose of the company or lie directly or indirectly within its activities.